Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis

Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. The Braille message on the balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, incorrectly states ‘CAPD/DPCA 19’. All other label information and printed data are correct for all above listed batches.

 

MHRA drug alert Date: 14/5/26

 

MHRA drug alert link:Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24 - GOV.UK

 

 

pip codeProduct descriptionSupplierBatch Numbers
Alliance do  not stockbalance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysisFresenius Medical Care Deutschland GmbHF4LM071
G4LB133
G4LL144
G4LM152
H4LB212
G4LI151

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For all medical information enquiries and information on this product, please email Medinfo-UK@freseniusmedicalcare.com, or telephone 01623 445 215. For stock control enquiries please email ukorders@freseniusmedicalcare.com, or telephone 01623 445 100.

 

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-Loperamide hydrochloride 2 mg Orodispersible Tablets

Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.

 

MHRA drug alert Date: 11/5/26

 

MHRA drug alert link:Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23 - GOV.UK

 

Pip code

Product description

Supplier

Batch Numbers

8103012

LOPERAMIDE OD TAB 2MG (6)

Milpharm Limited

25882X2

Alliance do  not stock

LOPERAMIDE OD TAB 2MG (12)

Milpharm Limited

25882X3

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

 

For all medical information enquiries and information on this product, please email medinfo@aurobindo.com, or telephone 020 8845 8811.

For stock control enquiries please email customerservices.uk@aurobindo.com, or telephone 020 8845 8811.

SUB-TYPE:

Alphega Pharmacy member success at the Scottish Pharmacy Awards

Alliance Healthcare UK, by Cencora proudly sponsored the Scottish Pharmacy Awards, Customer Award - championing collaboration and progress across the pharmacy sector. 

 

The awards celebrate excellence, leadership and innovation across community pharmacy in Scotland, and Alphega Pharmacy is extremely proud to see its members acknowledged for their outstanding contribution to patient care and pharmacy services.  


Congratulations to the award winners:  

 

  • Pharmacist of the Year – Glenn Davie, Barnton Pharmacy and Travel Clinic, Edinburgh  
  • Community Pharmacy Service Award – Lesley-Anne Graham, Lindsay & Gilmour, West Calder Health Centre  

 

Lesley-Anne Glenn

 

 

This recognition reflects the hard work, dedication and professionalism shown by Alphega members every day in serving their local communities. Achievements like these highlight the vital role community pharmacy continues to play across Scotland.  

 

Congratulations to both winners on this well‑deserved success and to all nominees. 

SUB-TYPE: CLASS 2 RECALL

Class 2 recall-Sertraline 100mg tablets

Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site.

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-amarox-limited-sertraline-100mg-film-coated-tablets-el-26-a-slash-22?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2339f367-dda6-4275-90fc-0e7281517b0d&utm_content=immediately

 

MHRA drug alert date: 28/04/26

 

Pip code

Product description

Supplier

Batch Numbers

1132612

SERTRALINE TAB 100MG ALM

Amarox Limited

V2500425

1125152

SERTRALINE TAB 100MG TEV

Amarox Limited

V2500425

1179407

SERTRALINE TAB 100MG ACC

Amarox Limited

V2500425

 

 

Further Information

For all medical information enquiries, information and for reporting of side effects please email Safety@Amaroxpharma.com or telephone +44 2039720005 and for stock control enquiries please email info@amaroxpharma.com or telephone +44 2039720002.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE:

Scotland - World Cup Bank Holiday Openings Hours

To help keep our customers informed of changes to our service, we have published our 2026 World Cup bank holiday opening hours for pharmacy and retail customers in Scotland:

 

Scotland World Cup bank holiday opening hours

SUB-TYPE: CLASS 3 RECALL

Class 3 recall-Napralief 9s

Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg Gastro-resistant tablets.

 

MHRA drug alert link: Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21 - GOV.UK

 

MHRA drug alert date:23/04/26

 

Pip code

Product description

Supplier

Batch Numbers

4365961

NAPRALIEF 9S

 OMEGA PHARMA LIMITED

B51496
B51497
B51102

 

 

Further Information

For all medical information enquiries, stock control queries and information on this product, please email UKLOcustomerservice@perrigo.com or call +44 0203 598 9603.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

 

 

 

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-PI Hiprex 1g tablets

Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).

 

MHRA drug alert Date: 26/3/26

 

MHRA drug alert link: Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20 - GOV.UK

 

Pip code

Product description

Supplier

Batch Numbers

8062713

PI HIPREX TAB 1G

Doncaster Pharma Limited

251352/BA
251358/BA
252137/BA
252137/BB
251358/BB

 

This is a caution in use only we are not accepting stock returns

 

Further Information

 

For all medical information enquiries and information on this product, please email regulatory@doncasterpharma.co.uk or quality.enquiries@doncasterpharma.co.uk, or telephone 01302 365 000.

For stock control enquiries, please email commercial@doncasterpharma.co.uk, or telephone 01302 365 000.

SUB-TYPE: CLASS 2 RECALL

Class 2 recall-Ramipril 10mg Caps

Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site.

 

MHRA drug alert link: Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19 - GOV.UK

 

MHRA drug alert date:20/04/26

 

Pip code

Product description

Supplier

Batch Numbers

1117878

RAMIPRIL CAP 10MG ALM

Crescent Pharma

GR174091

1112606

RAMIPRIL CAP 10MG ACC

Crescent Pharma

GR174091

1276070

RAMIPRIL CAP 10MG SDZ

Crescent Pharma

GR174091

1111541

RAMIPRIL CAP 10MG TEV

Crescent Pharma

GR174091

1219500

RAMIPRIL CAP 10MG WCK

Crescent Pharma

GR174091

 

 

Further Information

For all medical information enquiries and information, please email medinfo@crescentpharma.com, for reporting of side effects email safety@crescentpharma.com or telephone +44 1217901596 and for stock control enquiries please email complaints@crescentpharma.com

SUB-TYPE:

Alphega join Pharmacy Planet podcast

In Spring 26, Mandeep Mudhar, Head of Alphega Pharmacy UK, sat down with Boo Dhaliwal from Pharmacy Planet to discuss the importance of community pharmacy, leadership, strategy and more.  

 

Mandeep highlights opportunities in prescribing, NHS services, and wellness, while showcasing Alphega’s support through mentoring, compliance, and strategic guidance for pharmacy growth. The discussion also explores the challenges faced by independent community pharmacies today.

 

 Boo Dhaliwal and Mandeep Mudhar

 

The conversation covers:

 

• Mandeep’s journey from academia to pharmacy leadership  

• The shift from dispensing-focused pharmacies to service-led care

• The operational challenges facing independent contractors  

• How pharmacies can improve efficiency and category growth  

• The future of independent prescribing and NHS services  

• OTC, wellness, and supplement opportunities in pharmacy  

• How Alphega supports pharmacies with mentoring and compliance

 

Watch the full video here: Pharmacy Leadership: From Academia to the Frontline – Mandeep Mudhar’s Journey - YouTube  

SUB-TYPE: